New method of preparing gelatin microcapsules of soluble pharmaceuticals. 1978

P L Madan, and R K Jani, and A J Bartilucci

A new method of preparing gelatin microcapsules of soluble pharmaceuticals is described. Spherical droplets of a gelatin dispersion prepared in the drug solution were produced by the capillary method, and the droplets were congealed rapidly to yield discrete units in the form of a free-flowing powder. The microcapsules obtained were spherical in shape and showed no tendency to form agglomerates. Hardening of the microcapsules resulted in a significant reduction of the release rate without altering the reproducibility. The results indicated that the process of microencapsulation described is simple, reproducible, economical, and amenable to industrial application.

UI MeSH Term Description Entries
D008863 Microspheres Small uniformly-sized spherical particles, of micrometer dimensions, frequently labeled with radioisotopes or various reagents acting as tags or markers. Latex Beads,Latex Particles,Latex Spheres,Microbeads,Bead, Latex,Beads, Latex,Latex Bead,Latex Particle,Latex Sphere,Microbead,Microsphere,Particle, Latex,Particles, Latex,Sphere, Latex,Spheres, Latex
D002214 Capsules Hard or soft soluble containers used for the oral administration of medicine. Capsule,Microcapsule,Microcapsules
D004339 Drug Compounding The preparation, mixing, and assembly of a drug. (From Remington, The Science and Practice of Pharmacy, 19th ed, p1814). Drug Formulation,Drug Preparation,Drug Microencapsulation,Pharmaceutical Formulation,Compounding, Drug,Formulation, Drug,Formulation, Pharmaceutical,Microencapsulation, Drug,Preparation, Drug
D005780 Gelatin A product formed from skin, white connective tissue, or bone COLLAGEN. It is used as a protein food adjuvant, plasma substitute, hemostatic, suspending agent in pharmaceutical preparations, and in the manufacturing of capsules and suppositories. Gelafusal
D012980 Sodium Salicylate A non-steroidal anti-inflammatory agent that is less effective than equal doses of ASPIRIN in relieving pain and reducing fever. However, individuals who are hypersensitive to ASPIRIN may tolerate sodium salicylate. In general, this salicylate produces the same adverse reactions as ASPIRIN, but there is less occult gastrointestinal bleeding. (From AMA Drug Evaluations Annual, 1992, p120) Salicylate, Sodium
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

P L Madan, and R K Jani, and A J Bartilucci
January 1984, Journal of microencapsulation,
P L Madan, and R K Jani, and A J Bartilucci
January 2005, Artificial cells, blood substitutes, and immobilization biotechnology,
P L Madan, and R K Jani, and A J Bartilucci
March 1996, Pharmaceutical research,
P L Madan, and R K Jani, and A J Bartilucci
May 1975, Journal of pharmaceutical sciences,
P L Madan, and R K Jani, and A J Bartilucci
January 1968, The Journal of clinical pharmacology and the journal of new drugs,
P L Madan, and R K Jani, and A J Bartilucci
May 1998, Applied optics,
P L Madan, and R K Jani, and A J Bartilucci
January 1983, Zeitschrift fur medizinische Laboratoriumsdiagnostik,
P L Madan, and R K Jani, and A J Bartilucci
January 1983, Chemical & pharmaceutical bulletin,
P L Madan, and R K Jani, and A J Bartilucci
October 1926, British medical journal,
P L Madan, and R K Jani, and A J Bartilucci
March 1891, International dental journal (Philadelphia, Pa.),
Copied contents to your clipboard!